Horizon Discovery Horizon Discovery Licenses Gene-Edited Cell Line to Sanyou Biopharmaceuticals Sanyou will use the cell line in the development of preclinical antibody drug projects and to support its customers' human biotherapeutic products. PerkinElmer to Buy Horizon Discovery for $383M The deal allows PerkinElmer to expand its portfolio of automated life sciences discovery and applied genomics products to include gene editing and gene modulation tools. Horizon Discovery H1 Revenues Fall 14 Percent The gene editing and gene modulation technologies firm attributed the decline to the impact of the SARS-CoV-2 pandemic on its research reagents business. New Products Posted to GenomeWeb: Illumina, NIST, Horizon Discovery, More Horizon Discovery Revenues Up 8 Percent in 2019 The Cambridge, UK-based firm saw double-digit growth in its screening business and declines in its bioproduction and diagnostics businesses. Feb 21, 2020 Horizon Aims to Build Unique Portfolio of Gene Editing Tools While Avoiding IP Woes Premium Feb 4, 2020 Horizon Discovery Preliminary FY2019 Revenues Up 7 Percent Jan 30, 2020 Mammoth Biosciences Enters New Phase of Business Strategy With Horizon Deal, $45M Fundraise Premium Jan 16, 2020 JP Morgan Healthcare Day 3: Exact Sciences, NanoString, Natera, Horizon, Accelerate Dx, GenMark, More Jan 14, 2020 Rutgers Licenses Base Editing Tech to Horizon Discovery Jan 13, 2020 Horizon Discovery, Mammoth Biosciences Sign Second CRISPR Tools Development Agreement Dec 13, 2019 Horizon Discovery, Mammoth Biosciences Team Up to Develop CRISPR Tools Dec 13, 2019 New Products Posted to GenomeWeb: Horizon Discovery, Fluxion Biosciences, Caris Life Sciences, More Dec 3, 2019 Human Protein Atlas to Use Horizon Discovery Cell Models Sep 16, 2019 Horizon Discovery Revenues Up 14 Percent in H1 Mar 25, 2019 Horizon Discovery, St. George's University Hospital, EMQN to Develop NIPT Reference Material Jan 28, 2019 Horizon Discovery, Rutgers Collaborate to Commercialize CRISPR Base Editing Technology Sep 17, 2018 Horizon Discovery Revenues Double in H1 Aug 28, 2018 Horizon Discovery Begins Leveraging Vast Portfolio of Genome Editing Technology Premium Jul 18, 2018 Inscripta Confirms CRISPR-MAD7 Editing Activity in Mammalian Cells, Releases New MAD2 Enzyme Premium May 11, 2018 People in the News: Terry Pizzie, Stephanie Bywater, Michael Stocum May 9, 2018 Abcam Drops Takeover Bid for Horizon Discovery May 8, 2018 Horizon Discovery Preliminary 2017 Revenues Up 52 Percent May 2, 2018 Horizon Discovery Rejects £270M Takeover Offer From Abcam Dec 18, 2017 Roche, Horizon Ink IHC Reference Standard Development Deal Load More Breaking News Pediatric Medulloblastoma Subgroups May Benefit from Lower-Dose Radiation Therapy Space Radiation Shows Limited Effects on Mammalian Sperm DNA, Fertility Bluestar Genomics Sues Former Consultant, Ludwig Institute for Cancer Research Over IP Ownership New Products Posted to GenomeWeb: 10x Genomics, Swift Biosciences, Agilent Technologies, More In Brief This Week: Quantum-Si, TGen, Yale, and More People in the News: New Appointments at Invitae, PGDx, Oxford Nanopore, PacBio, More The Scan Fertility Fraud Found Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today. Ties Between Vigorous Exercise, ALS in Genetically At-Risk People Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports. Test Warning The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK. Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.